GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation

Hum Pathol. 2004 Feb;35(2):200-9. doi: 10.1016/j.humpath.2003.09.017.

Abstract

Hepatic vascular lesions in pediatric patients have overlapping definitions and a plethora of confusing terminology. The so-called hepatic infantile hemangioendothelioma (IHE) frequently coexists and shares some biological features with cutaneous juvenile hemangioma (CJH). To clarify the nature of hepatic vascular lesions in pediatric patients and to investigate the association between IHE and CJH, we reviewed the clinical features, imaging findings and histopathology of 19 cases of hepatic vascular lesions diagnosed at our institution over the last 33 years. Immunohistochemical stains for a battery of endothelial markers, including GLUT1, were performed. Our results indicate that there are two fundamentally different hepatic vascular lesions in infants and young children: GLUT1-positive hepatic infantile hemangioma (HIH) and GLUT1-negative hepatic vascular malformation with capillary proliferation (HVMCP). The finding of consistent GLUT1 immunoreactivity of endothelial cells in HIH not only offers a powerful tool to distinguish HIH from HVMCP, but also provides immunophenotypic evidence of the similar biological origins of CJH and HIH.

MeSH terms

  • Arteriovenous Malformations / etiology*
  • Arteriovenous Malformations / metabolism
  • Arteriovenous Malformations / pathology*
  • Arteriovenous Malformations / surgery
  • Child
  • Child, Preschool
  • Diagnosis, Differential
  • Endothelium, Vascular / metabolism*
  • Glucose Transporter Type 1
  • Hemangioma / metabolism*
  • Humans
  • Infant
  • Infant, Newborn
  • Liver / blood supply*
  • Liver Neoplasms / metabolism*
  • Monosaccharide Transport Proteins / metabolism*

Substances

  • Glucose Transporter Type 1
  • Monosaccharide Transport Proteins
  • SLC2A1 protein, human